Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SABS | AMGN | BMY | GILD | VRTX |
| Company | Sab Biotherapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 3.99 | 269.00 | 56.22 | 90.92 | 395.72 |
| High | 4.70 | 269.61 | 57.33 | 93.29 | 401.31 |
| Low | 3.85 | 262.21 | 56.08 | 90.71 | 386.49 |
| Last | 4.65 | 263.38 | 57.33 | 92.57 | 397.27 |
| Change | +0.75 | +2.19 | +1.03 | +1.48 | +0.63 |
| % Change | +19.23% | +0.84% | +1.83% | +1.62% | +0.16% |
| Volume | 116,500 | 13,687,900 | 48,212,000 | 22,530,100 | 6,203,100 |
| 20-Day Average Volume | 94,875 | 5,160,835 | 11,813,050 | 7,592,390 | 1,820,960 |
| Previous Close | 3.90 | 261.19 | 56.30 | 91.09 | 396.64 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.51 | 275.02 | 57.98 | 91.97 | 456.96 |
| 20-Day Raw Stochastic | 84.07% | 22.90% | 40.60% | 62.18% | 19.69% |
| 20-Day Relative Strength | 61.49% | 32.27% | 52.59% | 55.07% | 29.29% |
| Weighted Alpha | -32.94 | -14.54 | +17.93 | +25.30 | -11.23 |
| Today's Opinion | 72% Buy | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 64% Buy | 88% Sell | 80% Buy | 88% Buy | 56% Sell |
| Last Month's Opinion | 8% Buy | 40% Sell | 100% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.97% since 12/13/24 | -2.68% since 12/13/24 | +2.78% since 12/13/24 | +0.78% since 12/13/24 | -14.33% since 12/13/24 |
| Low | 3.32 on 12/18/24 | 253.30 on 12/19/24 | 55.68 on 12/16/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 4.70 on 12/20/24 | 272.69 on 12/16/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 | 474.18 on 12/17/24 |
| 1-Month | |||||
| %Chg | +51.96% since 11/20/24 | -8.51% since 11/20/24 | -0.95% since 11/20/24 | +4.45% since 11/20/24 | -11.96% since 11/20/24 |
| Low | 2.75 on 12/05/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 88.07 on 11/21/24 | 377.85 on 12/19/24 |
| High | 5.01 on 12/09/24 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | +37.17% since 09/20/24 | -21.93% since 09/20/24 | +16.03% since 09/20/24 | +10.28% since 09/20/24 | -14.55% since 09/20/24 |
| Low | 2.36 on 10/15/24 | 253.30 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 5.01 on 12/09/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +67.87% since 06/20/24 | -15.01% since 06/20/24 | +39.69% since 06/20/24 | +35.16% since 06/20/24 | -15.72% since 06/20/24 |
| Low | 2.16 on 08/14/24 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 5.01 on 12/09/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 42,916 | 141,575,456 | 116,275,392 | 115,366,840 | 102,308,544 |
| Shares Outstanding, K | 9,229 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 2,240,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -42,190,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 260,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -7,340,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 0.59 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.12 on 11/06/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/11/24 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.70 | 49.00 | 20.90 | 0.00 |